Other Event

Other Event

Other Adverse Events are non-serious adverse events that exceed a specific frequency threshold (typically 5% within any study arm). These events are reported to provide comprehensive safety information about all noteworthy adverse occurrences during clinical trials. Each other event is categorized by term, organ system, assessment type, and source vocabulary for standardized reporting.

Other Event path is as follows:

Study -> Results Section -> Adverse Events Module -> Other Event

Study -> Results Section -> Adverse Events Module -> Other Event -> Other Event Stats

Other Event


Ignite Creation Date: 2025-12-24 @ 11:41 PM
Ignite Modification Date: 2025-12-25 @ 9:32 PM
NCT ID: NCT01569451
Term: Infusion-related reaction
Organ System: General disorders
Assessment Type: NON_SYSTEMATIC_ASSESSMENT
Source Vocabulary: FDA guidlines
Notes: None
Study: NCT01569451
Study Brief: Comparison of Rituximab Induction Therapy Followed by Glatiramer Acetate
Other Event Stats (If Any):

Other Event Stats

Group ID # Events # Affected # At Risk View
EG000 13 11 27 View
EG001 42 19 28 View